|
The approval is based on data from the global Phase III SURPASS ET trial, demonstrating durable ELN responses and control.
|
 |
|
KOLs interviewed by GlobalData consistently recognized tirzepatide's cardiometabolic value as extending well beyond weight loss alone.
|
|
|
The joint effort began with AI-assisted IND submission preparation and has since expanded to HAQ and RTQ processes.
|
|
|
Aitia will use its platform to analyse clinical and omics data and construct digital models for predictions.
|
|
|
Karsten Eastman, CEO of Sethera Therapeutics, discusses developments in peptides from cutting-edge innovation to mass consumption.
|
|
